Reblozyl 75 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM3LF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,988
Award facts
- Contract value 100% obligated
- $51,987.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $52K to AmerisourceBergen Drug Corp for the supply of Reblozyl 75 mg vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of February 20, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to efficiently deliver a wide range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The competitively awarded delivery order continues AmerisourceBergen's established role as a key supplier of essential medications and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM3LF?
SPE2DR26FM3LF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FM3LF worth?
The government has obligated $51,988 on SPE2DR26FM3LF.
Is contract SPE2DR26FM3LF an order under another contract?
Yes. SPE2DR26FM3LF is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3LF competed?
The extent of competition for SPE2DR26FM3LF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award